Role of complement in demyelination in vitro by multiple sclerosis serum and other neurological disease sera
- 1 September 1984
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 65 (3) , 293-305
- https://doi.org/10.1016/0022-510x(84)90092-3
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- New approach to study of in vitro toxicity of multiple sclerosis and other seraJournal of the Neurological Sciences, 1984
- Antibody-independent complement activation by myelin via the classical complement pathway.The Journal of Experimental Medicine, 1982
- Experimental allergic encephalomyelitisJournal of the Neurological Sciences, 1981
- Diagnostic considerations in Guillain-Barr syndromeAnnals of Neurology, 1981
- Multiple sclerosisNeurology, 1980
- Multiple sclerosis: Immunochemical studies on the demyelinating serum factorBrain Research, 1979
- Myelin-binding antibodies in vitro. Immunoperoxidase studies with experimental allergic encephalomyelitis, anti-galactocerebroside and multiple sclerosis seraBrain Research, 1978
- DIFFERENT TYPES OF ANTIBODIES WITH A GLIOTOXIC EFFECT IN SERUM FROM ANIMALS WITH EXPERIMENTAL ALLERGIC ENCEPHALOMYELITISActa Pathologica Microbiologica Scandinavica, 1968
- TISSUE CULTURE STUDIES OF DEMYELINATION*Annals of the New York Academy of Sciences, 1965
- THE APPLICATION OF TISSUE CULTURE TO THE STUDY OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITISThe Journal of Experimental Medicine, 1964